WHITMORE BRADFORD T - 30 Oct 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
10%+ Owner
Signature
Bradford T. Whitmore
Issuer symbol
CLSD
Transactions as of
30 Oct 2023
Transactions value $
$99,849
Form type
4
Filing time
01 Nov 2023, 16:24:36 UTC
Previous filing
01 Nov 2023
Next filing
29 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $411 +600 +0.02% $0.69 3.92M 30 Oct 2023 Direct
transaction CLSD Common Stock Purchase $51.5K +70.8K +1.81% $0.73 3.99M 31 Oct 2023 Direct F1
transaction CLSD Common Stock Purchase $47.9K +64.4K +1.61% $0.74 4.05M 01 Nov 2023 Direct F2
holding CLSD Common Stock 2.35M 30 Oct 2023 by Grace Brothers, LP F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.707 to $0.73. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.693 to $0.7656. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F3 As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock.